Lenalidomide is active for extramedullary disease in refractory multiple myeloma

Annals of Hematology

Volumn 91, Issue 3, 2012, Pages 473-474

  Nakazato, Tomonori ^a   Mihara, Ai ^a   Ito, Chisako ^a   Sanada, Yukinari ^a   Aisa, Yoshinobu ^a  

^a YOKOHAMA MUNICIPAL CITIZEN'S HOSPITAL   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN LAMBDA CHAIN; IMMUNOGLOBULIN M; LENALIDOMIDE; MELPHALAN; PREDNISOLONE; VINCRISTINE;

AGED; BACTERIAL PNEUMONIA; BLOOD ANALYSIS; CANCER REGRESSION; CANCER STAGING; CANCER SURVIVAL; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG MEGADOSE; DRUG WITHDRAWAL; FEBRILE NEUTROPENIA; FOLLOW UP; HUMAN; LETTER; MALE; MULTIPLE CYCLE TREATMENT; MULTIPLE MYELOMA; PLASMACYTOMA; PRIORITY JOURNAL; TREATMENT DURATION; TREATMENT OUTCOME; TUMOR VOLUME;

AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; HUMANS; MALE; MULTIPLE MYELOMA; PLASMACYTOMA; SARCOMA, MYELOID; THALIDOMIDE;

EID: 84857373538     PISSN: 09395555     EISSN: 14320584     Source Type: Journal    
DOI: 10.1007/s00277-011-1272-6     Document Type: Letter

References (6)

1. M Varettoni A Corso G Pica S Mangiacavalli C Pascutto M Lazzarino 2010 Incidence, presenting features and outcome of extramedullary disease in multiple myeloma: a longitudinal study on 1,003 consecutive patients Ann Oncol 21 325 330 19633044 10.1093/annonc/mdp329 1:STN:280:DC%2BC3c%2Fls1entQ%3D%3D
2. J Blade M Perales L Rosinol, et al. 2001 Thalidomide in multiple myeloma: lack of response of soft-tissue plasmacytomas Br J Haematol 113 422 424 11380408 10.1046/j.1365-2141.2001.02765.x 1:CAS:528:DC%2BD3MXkvVOhtL0%3D (Pubitemid 32523147)
3. L Rosinol MT Cibeira J Blade, et al. 2004 Extramedullary multiple myeloma escapes the effect of thalidomide Haematologica 89 832 836 15257935 1:CAS:528:DC%2BD2cXnsFSmsLg%3D (Pubitemid 38981343)
4. R Laura MT Cibeira C Uriburu, et al. 2006 Bortezomib: an effective agent in extramedullary disease in multiple myeloma Eur J Haematol 76 405 408 16529604 10.1111/j.0902-4441.2005.t01-1-EJH2462.x
5. F Patriarca S Prosdocimo V Tomadini, et al. 2005 Efficacy of bortezomib therapy for extramedullary relapse of myeloma after autologous and non-myeloablative allogeneic transplantation Haematologica 90 278 279 15710593 (Pubitemid 40293302)
6. T Sher KC Miller K Lee A Chanan-Khan 2009 Remission induction with lenalidomide alone in a patient with previously untreated plasmablastic myeloma: a case report Clin Lymphoma Myeloma 9 328 330 19717386 10.3816/CLM.2009.n.065 1:CAS:528:DC%2BD1MXhtF2qs73J